thalidomide has been researched along with Hemangioendothelioma, Epithelioid in 6 studies
Thalidomide: A piperidinyl isoindole originally introduced as a non-barbiturate hypnotic, but withdrawn from the market due to teratogenic effects. It has been reintroduced and used for a number of immunological and inflammatory disorders. Thalidomide displays immunosuppressive and anti-angiogenic activity. It inhibits release of TUMOR NECROSIS FACTOR-ALPHA from monocytes, and modulates other cytokine action.
thalidomide : A racemate comprising equimolar amounts of R- and S-thalidomide.
2-(2,6-dioxopiperidin-3-yl)-1H-isoindole-1,3(2H)-dione : A dicarboximide that is isoindole-1,3(2H)-dione in which the hydrogen attached to the nitrogen is substituted by a 2,6-dioxopiperidin-3-yl group.
Hemangioendothelioma, Epithelioid: A tumor of medium-to-large veins, composed of plump-to-spindled endothelial cells that bulge into vascular spaces in a tombstone-like fashion. These tumors are thought to have borderline aggression, where one-third develop local recurrences, but only rarely metastasize. It is unclear whether the epithelioid hemangioendothelioma is truly neoplastic or an exuberant tissue reaction, nor is it clear if this is equivalent to Kimura's disease (see ANGIOLYMPHOID HYPERPLASIA WITH EOSINOPHILIA). (Segen, Dictionary of Modern Medicine, 1992)
| Excerpt | Relevance | Reference |
|---|---|---|
| " Although treatment was initiated with thalidomide, the patient developed multiple organ dysfunction syndrome (MODS) and succumbed to his disease." | 3.73 | Multifocal epithelioid hemangioendothelioma: case report of a clinical chamaeleon. ( Bölke, E; Budach, W; Gripp, S; Orth, K; Peiper, M; Reinecke, P; Schwarz, A; van de Nes, JA, 2006) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (50.00) | 29.6817 |
| 2010's | 3 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Pallotti, MC | 1 |
| Nannini, M | 1 |
| Agostinelli, C | 1 |
| Leoni, S | 1 |
| Scioscio, VD | 1 |
| Mandrioli, A | 1 |
| Lolli, C | 1 |
| Saponara, M | 1 |
| Pileri, S | 1 |
| Bolondi, L | 1 |
| Biasco, G | 1 |
| Pantaleo, MA | 1 |
| Gurung, S | 1 |
| Fu, H | 1 |
| Zhang, WW | 1 |
| Gu, YH | 1 |
| Kassam, A | 1 |
| Mandel, K | 1 |
| Sumrall, A | 1 |
| Fredericks, R | 1 |
| Berthold, A | 1 |
| Shumaker, G | 1 |
| Mascarenhas, RC | 1 |
| Sanghvi, AN | 1 |
| Friedlander, L | 1 |
| Geyer, SJ | 1 |
| Beasley, HS | 1 |
| Van Thiel, DH | 1 |
| Bölke, E | 1 |
| Gripp, S | 1 |
| Peiper, M | 1 |
| Budach, W | 1 |
| Schwarz, A | 1 |
| Orth, K | 1 |
| Reinecke, P | 1 |
| van de Nes, JA | 1 |
1 review available for thalidomide and Hemangioendothelioma, Epithelioid
| Article | Year |
|---|---|
Hepatic epithelioid hemangioendothelioma metastasized to the peritoneum, omentum and mesentery: a case report.
Topics: Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Biopsy; Diagnosis, Differential; | 2015 |
5 other studies available for thalidomide and Hemangioendothelioma, Epithelioid
| Article | Year |
|---|---|
Long-term durable response to lenalidomide in a patient with hepatic epithelioid hemangioendothelioma.
Topics: Aged; Angiogenesis Inhibitors; Antigens, CD34; Biomarkers, Tumor; Biopsy; Hemangioendothelioma, Epit | 2014 |
Metastatic hepatic epithelioid hemangioendothelioma in a teenage girl.
Topics: Adolescent; Angiogenesis Inhibitors; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Ce | 2008 |
Lenalidomide stops progression of multifocal epithelioid hemangioendothelioma including intracranial disease.
Topics: Adult; Antineoplastic Agents; Brain Neoplasms; Clinical Trials as Topic; Female; Hemangioendotheliom | 2010 |
Thalidomide inhibits the growth and progression of hepatic epithelioid hemangioendothelioma.
Topics: Angiogenesis Inhibitors; Antineoplastic Agents; Disease Progression; Drug Administration Schedule; H | 2004 |
Multifocal epithelioid hemangioendothelioma: case report of a clinical chamaeleon.
Topics: Angiogenesis Inhibitors; Diagnosis, Differential; Fatal Outcome; Hemangioendothelioma, Epithelioid; | 2006 |